Neumora Therapeutics, Inc.

Siren, L.L.C. NMRA
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/13/2026
Shares
6,288,783
Value ($000)
11,257
Weight
0.3%
2024 Q3 - 2025 Q4 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).